Special considerations in infants and children

Ann-Christine Duhaime1, Rima Sestokas Rindler2

  • 1Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA.

Insights

Pediatric head injury is a major cause of death and disability. Further research and large datasets are needed to optimize treatment and recovery for children with head injuries.

Area of Science:

  • Pediatric Neurology
  • Traumatology
  • Neuroscience

Background:

  • Head injury is a leading cause of death and disability in children globally.
  • Pediatric head injury presents unique challenges compared to adult injuries.

Purpose of the Study:

  • To review the causes, patterns, pathophysiology, and treatment of pediatric head injury.
  • To compare head injury in children to that in adults.
  • To highlight areas needing further research for optimal clinical interventions.

Main Methods:

  • Review of existing literature on pediatric head injury.
  • Discussion of classification systems (severity, pathoanatomic type, mechanism).
  • Examination of age-specific neuroassessment tools and advanced imaging (MRI).

Main Results:

  • Response and repair mechanisms in pediatric head injury vary by age.
  • Specific management issues like intracranial pressure (ICP) monitoring and seizure prophylaxis are crucial.
  • Functional outcomes and injury patterns in pediatric patients require further study.

Conclusions:

  • Optimal treatment for pediatric head injury requires more research, especially for milder injuries.
  • Large, collaborative international datasets are essential for understanding age-specific injury evolution.
  • Future research should focus on pathophysiologic, treatment, and genetic factors influencing recovery.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
863
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
904
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
507
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
362